Bringing the future into focus

Key publications 2012

Caramoy A, Foerster J, Allakhiarova E, Hoyng CB, Droge K, Kirchhof B, Fauser S. Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials. Br J Ophthalmol 2012; 96(10):1325-1330. Pubmed

Fett AL, Hermann MM, Muether PS, Kirchhof B, Fauser S. Immunohistochemical localization of complement regulatory proteins in the human retina. Histol Histopathol 2012; 27(3):357-364. Pubmed

Hermann M, Caramoy A, Schroder S, Droge K, Kirchhof B, Fauser S. Prevalence of age-related macular degeneration in persons aged 90 years and older in Cologne. Acta Ophthalmol 2012; 90(6):e500-501. Pubmed

Keane PA, Patel PJ, Liakopoulos S, Heussen FM, Sadda SR, Tufail A. Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol 2012; 57(5):389-414. Pubmed

Koch KR, Muether PS, Hermann MM, Hoerster R, Kirchhof B, Fauser S. Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD. Graefes Arch Clin Exp Ophthalmol 2012; 250(2):201-209. Pubmed

Lechanteur YT, van de Ven JP, Smailhodzic D, Boon CJ, Klevering BJ, Fauser S, Groenewoud JM, van der Wilt BJ, den Hollander AI, Hoyng CB. Genetic, behavioral and sociodemographic risk factors for second eye progression in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53(9):5846-5852. Pubmed 

Muether PS, Herman MM, Viebahn U, Kirchhof B, Fauser S. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Ophthalmology 2012; 119(10):2082-2086. Pubmed

Smailhodzic D, Klaver CC, Klevering BJ, Boon CJ, Groenewoud JM, Kirchhof B, Daha MR, den Hollander AI, Hoyng CB. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology 2012; 119(2):339-346. Pubmed

Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, van de Ven JPH, Keunen JEE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibuzumab treatment in age-related macular degeneration. Ophthalmology 2012; 119(11):2304-2311. Pubmed

Van de Ven JP, Boon CJ, Fauser S, Hoefsloot LH, Smailhodzic D, Schoenmaker-Koller F, Klevering BJ, Klaver CC, den Hollander AI, Hoyng CB. Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene. Arch Ophthalmol 2012; 130(8):1038-1047. Pubmed

Van de Ven JP, Boon CJ, Smailhodzic D, Lechanteur YT, den Hollander AI, Hoyng CB, Theelen T. Short-term changes of basal laminar drusen on spectral-domain optical coherence tomography. Am J  Ophthalmol 2012; 154(3):560-567. Pubmed

Van de Ven JP, Smailhodzic D, Boon CJF, Fauser S, Groenewoud JMM, Chong NV, Hoyng CB, Klevering BJ, den Hollander AI. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol Vis 2012; 18:2271-2278. Pubmed

Westeneng-van Haaften SC, Boon CJ, Cremers FPM, Hoefsloot LH, den Hollander AI, Hoyng CB. Clinical and genetic characteristics of late-onset Stargardt's disease. Ophthalmology 2012; 119(6):1199-1210. Pubmed